La Jolla Institute-led team illuminates cell pathway key to insulin resistance in Type 2 diabetes
SAN DIEGO — (February 24, 2011) — A research team, led by La Jolla Institute scientist Joel Linden, Ph.D., has shed new light on the problem of insulin resistance, and identified the key participants in a molecular pathway that holds therapeu…